Loop Medical, a healthcare company reinventing blood collection, today announced it has completed a $6.4 million Series A financing round led by SARSTEDT Group and Casdin Capital. Proceeds of the round will go towards U.S. FDA clearance and ramped-up manufacturing of its painless and easy-to-use blood collection device. The device will be targeted to the home, clinical trial, and liquid biopsy testing markets for a combined total addressable market of $5.2 billion.
“This investment further validates our technology and the significant market opportunity we have ahead of us,” said Arthur Queval, founder and CEO of Loop Medical. “We thank SARSTEDT Group and Casdin Capital for sharing the belief in our potential and look forward to bringing our technology to U.S. healthcare providers, labs, and patients.”Loop Medical SA: Loop is developing a painless blood collection technology
Loop medical is developing an easy and painless blood collection technology compatible with existing laboratory infrastructure. Established in 2017, Loop Medical is backed by market leader Sarstedt an... Read more